162 related articles for article (PubMed ID: 33739293)
1. e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study.
Smit MA; van Pelt GW; Dequeker EM; Al Dieri R; Tollenaar RA; van Krieken JHJ; Mesker WE;
JMIR Form Res; 2021 Mar; 5(3):e19408. PubMed ID: 33739293
[TBL] [Abstract][Full Text] [Related]
2. Uniform Noting for International Application of the Tumor-Stroma Ratio as an Easy Diagnostic Tool: Protocol for a Multicenter Prospective Cohort Study.
Smit M; van Pelt G; Roodvoets A; Meershoek-Klein Kranenbarg E; Putter H; Tollenaar R; van Krieken JH; Mesker W
JMIR Res Protoc; 2019 Jun; 8(6):e13464. PubMed ID: 31199317
[TBL] [Abstract][Full Text] [Related]
3. Deep learning based tumor-stroma ratio scoring in colon cancer correlates with microscopic assessment.
Smit MA; Ciompi F; Bokhorst JM; van Pelt GW; Geessink OGF; Putter H; Tollenaar RAEM; van Krieken JHJM; Mesker WE; van der Laak JAWM
J Pathol Inform; 2023; 14():100191. PubMed ID: 36794267
[TBL] [Abstract][Full Text] [Related]
4. Standardized Assessment of the Tumor-Stroma Ratio in Colorectal Cancer: Interobserver Validation and Reproducibility of a Potential Prognostic Factor.
Souza da Silva RM; Queiroga EM; Paz AR; Neves FFP; Cunha KS; Dias EP
Clin Pathol; 2021; 14():2632010X21989686. PubMed ID: 33634262
[TBL] [Abstract][Full Text] [Related]
5. Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study.
Smit MA; van Pelt GW; Terpstra V; Putter H; Tollenaar RAEM; Mesker WE; van Krieken JHJM
Int J Colorectal Dis; 2021 Dec; 36(12):2729-2737. PubMed ID: 34533595
[TBL] [Abstract][Full Text] [Related]
6. Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations.
van Pelt GW; Kjær-Frifeldt S; van Krieken JHJM; Al Dieri R; Morreau H; Tollenaar RAEM; Sørensen FB; Mesker WE
Virchows Arch; 2018 Oct; 473(4):405-412. PubMed ID: 30030621
[TBL] [Abstract][Full Text] [Related]
7. Domain-specific transfer learning in the automated scoring of tumor-stroma ratio from histopathological images of colorectal cancer.
Petäinen L; Väyrynen JP; Ruusuvuori P; Pölönen I; Äyrämö S; Kuopio T
PLoS One; 2023; 18(5):e0286270. PubMed ID: 37235626
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and effectiveness of automatic deep learning network and radiomics models for differentiating tumor stroma ratio in pancreatic ductal adenocarcinoma.
Liao H; Yuan J; Liu C; Zhang J; Yang Y; Liang H; Jiang S; Chen S; Li Y; Liu Y
Insights Imaging; 2023 Dec; 14(1):223. PubMed ID: 38129708
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of tumor-stroma ratio and a newly developed computer-aided quantitative analysis of routine H&E slides in high-grade serous ovarian cancer.
van Wagensveld L; Walker C; Hahn K; Sanders J; Kruitwagen R; van der Aa M; Sonke G; Rottenberg S; Van de Vijver K; Janowczyk A; Horlings H
Res Sq; 2023 Nov; ():. PubMed ID: 38014112
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer.
Zhao K; Li Z; Yao S; Wang Y; Wu X; Xu Z; Wu L; Huang Y; Liang C; Liu Z
EBioMedicine; 2020 Nov; 61():103054. PubMed ID: 33039706
[TBL] [Abstract][Full Text] [Related]
11. Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: A retrospective cohort study.
Scheer R; Baidoshvili A; Zoidze S; Elferink MAG; Berkel AEM; Klaase JM; van Diest PJ
World J Gastrointest Oncol; 2017 Dec; 9(12):466-474. PubMed ID: 29290917
[TBL] [Abstract][Full Text] [Related]
12. Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer.
Zheng Q; Jiang Z; Ni X; Yang S; Jiao P; Wu J; Xiong L; Yuan J; Wang J; Jian J; Wang L; Yang R; Chen Z; Liu X
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769068
[TBL] [Abstract][Full Text] [Related]
13. Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma.
Jiang J; Tekin B; Yuan L; Armasu S; Winham SJ; Goode EL; Liu H; Huang Y; Guo R; Wang C
Front Med (Lausanne); 2022; 9():994467. PubMed ID: 36160147
[TBL] [Abstract][Full Text] [Related]
14. Standardization of the tumor-stroma ratio scoring method for breast cancer research.
Hagenaars SC; Vangangelt KMH; Van Pelt GW; Karancsi Z; Tollenaar RAEM; Green AR; Rakha EA; Kulka J; Mesker WE
Breast Cancer Res Treat; 2022 Jun; 193(3):545-553. PubMed ID: 35429321
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Stroma Ratio in Colorectal Cancer-Comparison between Human Estimation and Automated Assessment.
Firmbach D; Benz M; Kuritcyn P; Bruns V; Lang-Schwarz C; Stuebs FA; Merkel S; Leikauf LS; Braunschweig AL; Oldenburger A; Gloßner L; Abele N; Eck C; Matek C; Hartmann A; Geppert CI
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345012
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the tumor-stroma ratio in gallbladder cancer.
Li H; Yuan SL; Han ZZ; Huang J; Cui L; Jiang CQ; Zhang Y
Neoplasma; 2017; 64(4):588-593. PubMed ID: 28485165
[TBL] [Abstract][Full Text] [Related]
17. Tumour-stroma ratio (TSR) in breast cancer: comparison of scoring core biopsies versus resection specimens.
Karancsi Z; Hagenaars SC; Németh K; Mesker WE; Tőkés AM; Kulka J
Virchows Arch; 2023 May; ():. PubMed ID: 37198327
[TBL] [Abstract][Full Text] [Related]
18. Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma.
Liu J; Liu J; Li J; Chen Y; Guan X; Wu X; Hao C; Sun Y; Wang Y; Wang X
Gynecol Oncol; 2014 Jan; 132(1):81-6. PubMed ID: 24219981
[TBL] [Abstract][Full Text] [Related]
19. Tumor-stroma ratio predicts recurrence in patients with colon cancer treated with neoadjuvant chemotherapy.
Hansen TF; Kjær-Frifeldt S; Lindebjerg J; Rafaelsen SR; Jensen LH; Jakobsen A; Sørensen FB
Acta Oncol; 2018 Apr; 57(4):528-533. PubMed ID: 28980848
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients.
Vangangelt KMH; Tollenaar LSA; van Pelt GW; de Kruijf EM; Dekker TJA; Kuppen PJK; Tollenaar RAEM; Mesker WE
Int J Cancer; 2018 Dec; 143(12):3194-3200. PubMed ID: 29978463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
